SYSTEMATIC REVIEW article
Front. Surg.
Sec. Thoracic Surgery
Volume 12 - 2025 | doi: 10.3389/fsurg.2025.1671783
The Role of Nutritional and Inflammatory Markers in Predicting Postoperative Complications after Esophagectomy for Esophageal Squamous Cell Carcinoma: Mechanisms, Clinical Applications, and Future Perspectives
Provisionally accepted
- The Affiliated Huai'an No. 1 People's Hospital of Nanjing Medical University, Huai'an, China, Huai'an, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Esophageal squamous cell carcinoma (ESCC) is a prevalent malignancy with a high mortality rate, for which esophagectomy remains the cornerstone of curative treatment. However, this complex surgical procedure is associated with significant postoperative morbidity and mortality. Nutritional status and systemic inflammatory response are critically intertwined and play a pivotal role in the host's ability to withstand surgical stress and mount an effective recovery. This review aims to provide a comprehensive overview of the role of nutritional and inflammatory markers in predicting postoperative complications following esophagectomy for ESCC. We first elucidate the intricate biological mechanisms through which malnutrition and systemic inflammation compromise tissue repair, immune function, and overall surgical outcomes. We then systematically evaluate the predictive value of various individual markers, such as albumin, C-reactive protein (CRP), and neutrophil-to-lymphocyte ratio (NLR), as well as combined scoring systems like the Prognostic Nutritional Index (PNI) and the Glasgow Prognostic Score (GPS). The clinical application of these markers in preoperative risk stratification, guiding perioperative immunonutrition, and dynamic monitoring for early complication detection is thoroughly discussed. Finally, we highlight future perspectives, including the integration of novel biomarkers from metabolomics and proteomics, the application of artificial intelligence in building sophisticated prediction models, and the design of marker-guided precision intervention trials. A deeper understanding and smarter utilization of these readily available and cost-effective markers will pave the way for personalized perioperative management, ultimately improving the prognosis for patients with ESCC undergoing esophagectomy.
Keywords: esophageal squamous cell carcinoma, Esophagectomy, Postoperativecomplications, nutritional markers, Inflammatory markers, Prediction model
Received: 23 Jul 2025; Accepted: 18 Sep 2025.
Copyright: © 2025 Shi, Tang, Shen, Xu, Tian and Xu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Wen Ze Tian, hayytwz@njmu.edu.cn
Zhiyun Xu, zhiyunxu2012@njmu.edu.cn
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.